Hypertension, diabetes and dyslipidemia are three important risk factors contributing to cardio-cerebrovascular diseases in China. Hanhui Pharma has deployed three major fields of blood pressure, blood lipids and blood sugar, with the patient as the core focus, and facilitate the promotion of the country's “common management of three highs” project and improvement the health management of chronic diseases and other important strategic deployment.
Hypertension, diabetes and dyslipidemia are three important risk factors contributing to cardio-cerebrovascular diseases in China. Hanhui Pharma has deployed three major fields of blood pressure, blood lipids and blood sugar, with the patient as the core focus, and facilitate the promotion of the country's “common management of three highs” project and improvement the health management of chronic diseases and other important strategic deployment.
